| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGA3 CDHR1 FAT3 PCDHB5 PCDHB14 SYT9 CDH23 LRP1B FAT1 FAT2 SULF2 HMCN1 MEGF6 CCDC47 USP32 MACF1 EGFLAM CDH15 RCN3 | 5.79e-06 | 749 | 155 | 19 | GO:0005509 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHGA3 CDHR1 FAT3 PCDHB5 PCDHB14 CDH23 FAT1 FAT2 HMCN1 PTPRR ROBO3 SDK1 CDH15 | 1.71e-09 | 187 | 155 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHGA3 CDHR1 FAT3 PCDHB5 PCDHB14 CDH23 FAT1 FAT2 HMCN1 PTPRR ROBO3 SDK1 CDH15 | 7.32e-07 | 313 | 155 | 13 | GO:0098742 |
| Domain | Cadherin_CS | 3.11e-07 | 109 | 155 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 4.23e-07 | 113 | 155 | 9 | PS00232 | |
| Domain | Cadherin | 4.23e-07 | 113 | 155 | 9 | PF00028 | |
| Domain | CADHERIN_2 | 4.56e-07 | 114 | 155 | 9 | PS50268 | |
| Domain | - | 4.56e-07 | 114 | 155 | 9 | 2.60.40.60 | |
| Domain | CA | 4.92e-07 | 115 | 155 | 9 | SM00112 | |
| Domain | Cadherin-like | 5.29e-07 | 116 | 155 | 9 | IPR015919 | |
| Domain | Cadherin | 6.12e-07 | 118 | 155 | 9 | IPR002126 | |
| Domain | EGF_CA | 7.14e-05 | 122 | 155 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.91e-05 | 124 | 155 | 7 | IPR001881 | |
| Domain | LAM_G_DOMAIN | 2.70e-04 | 38 | 155 | 4 | PS50025 | |
| Domain | EGF_1 | 2.85e-04 | 255 | 155 | 9 | PS00022 | |
| Domain | Laminin_G_2 | 3.30e-04 | 40 | 155 | 4 | PF02210 | |
| Domain | EGF-like_CS | 3.38e-04 | 261 | 155 | 9 | IPR013032 | |
| Domain | EGF_2 | 3.77e-04 | 265 | 155 | 9 | PS01186 | |
| Domain | LamG | 4.78e-04 | 44 | 155 | 4 | SM00282 | |
| Domain | dsrm | 5.76e-04 | 20 | 155 | 3 | PF00035 | |
| Domain | EGF | 6.44e-04 | 126 | 155 | 6 | PF00008 | |
| Domain | DS_RBD | 6.68e-04 | 21 | 155 | 3 | PS50137 | |
| Domain | NUT | 6.73e-04 | 5 | 155 | 2 | IPR024310 | |
| Domain | NUT_N | 6.73e-04 | 5 | 155 | 2 | IPR024309 | |
| Domain | NUT | 6.73e-04 | 5 | 155 | 2 | PF12881 | |
| Domain | EGF_CA | 7.48e-04 | 86 | 155 | 5 | PF07645 | |
| Domain | EGF | 7.86e-04 | 235 | 155 | 8 | SM00181 | |
| Domain | EGF_3 | 7.86e-04 | 235 | 155 | 8 | PS50026 | |
| Domain | ADEAMc | 1.00e-03 | 6 | 155 | 2 | SM00552 | |
| Domain | A_deamin | 1.00e-03 | 6 | 155 | 2 | PF02137 | |
| Domain | A_DEAMIN_EDITASE | 1.00e-03 | 6 | 155 | 2 | PS50141 | |
| Domain | A_deamin | 1.00e-03 | 6 | 155 | 2 | IPR002466 | |
| Domain | LRR_6 | 1.12e-03 | 55 | 155 | 4 | PF13516 | |
| Domain | EGF-like_dom | 1.14e-03 | 249 | 155 | 8 | IPR000742 | |
| Domain | EGF_Ca-bd_CS | 1.29e-03 | 97 | 155 | 5 | IPR018097 | |
| Domain | Laminin_G | 1.37e-03 | 58 | 155 | 4 | IPR001791 | |
| Domain | ENaC | 1.40e-03 | 7 | 155 | 2 | IPR004724 | |
| Domain | EGF_CA | 1.41e-03 | 99 | 155 | 5 | PS01187 | |
| Domain | Znf_FYVE_PHD | 1.43e-03 | 147 | 155 | 6 | IPR011011 | |
| Domain | - | 1.47e-03 | 321 | 155 | 9 | 3.80.10.10 | |
| Domain | ASX_HYDROXYL | 1.47e-03 | 100 | 155 | 5 | PS00010 | |
| Domain | L_dom-like | 1.70e-03 | 328 | 155 | 9 | IPR032675 | |
| Domain | Spectrin_repeat | 1.75e-03 | 29 | 155 | 3 | IPR002017 | |
| Domain | DHC_N1 | 1.85e-03 | 8 | 155 | 2 | PF08385 | |
| Domain | Na+channel_ASC_CS | 1.85e-03 | 8 | 155 | 2 | IPR020903 | |
| Domain | Dynein_heavy_dom-1 | 1.85e-03 | 8 | 155 | 2 | IPR013594 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.91e-03 | 106 | 155 | 5 | IPR000152 | |
| Domain | Leu-rich_rpt | 1.95e-03 | 271 | 155 | 8 | IPR001611 | |
| Domain | CH | 2.09e-03 | 65 | 155 | 4 | SM00033 | |
| Domain | SPEC | 2.33e-03 | 32 | 155 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.33e-03 | 32 | 155 | 3 | IPR018159 | |
| Domain | ASC | 2.37e-03 | 9 | 155 | 2 | PF00858 | |
| Domain | ASC | 2.37e-03 | 9 | 155 | 2 | PS01206 | |
| Domain | Na+channel_ASC | 2.37e-03 | 9 | 155 | 2 | IPR001873 | |
| Pubmed | THSD7A MYCBP2 DOCK10 SULF2 AATK MEGF6 UBR5 SYNE2 PHLPP1 MACF1 CLEC16A | 8.12e-09 | 225 | 159 | 11 | 12168954 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 MAN2B2 POLR1A MYCBP2 EVC ADARB1 RXRA LRCH3 RLF CMIP MEGF6 INTS2 PTPRR RPTOR NAXD SHPRH NLRC5 MACF1 AKAP13 CLEC16A ALG12 WNK2 NLK CDH15 CAP2 | 1.93e-08 | 1489 | 159 | 25 | 28611215 |
| Pubmed | LRCH2 TMEM94 HIPK1 DOCK10 CAMTA2 DHX30 UBR5 MACF1 MAPKBP1 PUM1 KIF17 CLEC16A DYNC1H1 | 5.50e-08 | 407 | 159 | 13 | 12693553 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 9.38e-08 | 3 | 159 | 3 | 15744052 | |
| Pubmed | THSD7A MYCBP2 HIPK1 RXRA DHX30 RLF UBR5 MACF1 PUM1 UHRF2 SDK1 DYNC1H1 CAP2 HDLBP | 6.33e-07 | 591 | 159 | 14 | 15231748 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 ERCC2 MYCBP2 TMEM94 ARHGEF11 DHX30 NOD2 FAT1 AATK MEGF6 RPTOR NLRC5 AKAP13 ZFYVE26 MAPKBP1 PUM1 MED13 DYNC1H1 WNK2 | 8.02e-07 | 1105 | 159 | 19 | 35748872 |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 16059920 | ||
| Pubmed | USP36 BRPF3 ERCC2 ZNF609 MTHFD2 KDM5C FAT3 HMGXB4 E2F2 TAF6L FAT1 SULF2 ARSB UBR5 PIK3R2 RPTOR MACF1 CDH15 | 3.89e-06 | 1116 | 159 | 18 | 31753913 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 4.54e-06 | 143 | 159 | 7 | 30397336 | |
| Pubmed | USP36 KDM3A BRPF3 ZNF609 CAND2 KDM5C SULF2 INTS2 RPTOR TET1 MED13 WNK2 | 6.39e-06 | 529 | 159 | 12 | 14621295 | |
| Pubmed | NPC1 HDAC9 KDM3A MYCBP2 HIPK1 ADARB1 LRP1B DHX30 ZNF18 HEATR6 STXBP1 PSMG1 USP32 MAP3K10 MACF1 ABHD12 MED13 DYNC1H1 CAP2 | 7.15e-06 | 1285 | 159 | 19 | 35914814 | |
| Pubmed | 8.71e-06 | 104 | 159 | 6 | 9205841 | ||
| Pubmed | HDAC9 HIPK1 LCP2 ARHGEF11 PIK3R2 MAP3K10 MACF1 AKAP13 WNK2 CAP2 HDLBP | 1.60e-05 | 486 | 159 | 11 | 20936779 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12087094 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 36376971 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8876669 | ||
| Pubmed | ASICs mediate fast excitatory synaptic transmission for tactile discrimination. | 2.08e-05 | 2 | 159 | 2 | 38359825 | |
| Pubmed | PHLPPing through history: a decade in the life of PHLPP phosphatases. | 2.08e-05 | 2 | 159 | 2 | 27913677 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22700971 | ||
| Pubmed | Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma. | 2.08e-05 | 2 | 159 | 2 | 27051024 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 35069585 | ||
| Pubmed | TET1 promotes RXRα expression and adipogenesis through DNA demethylation. | 2.08e-05 | 2 | 159 | 2 | 33684567 | |
| Pubmed | Ras-associating domain proteins: a new class of cyclic nucleotide-gated channel modulators. | 2.08e-05 | 2 | 159 | 2 | 22183406 | |
| Pubmed | Long noncoding RNA FER1L4 regulates rheumatoid arthritis via targeting NLRC5. | 2.08e-05 | 2 | 159 | 2 | 31694750 | |
| Pubmed | Acid sensing ion channels 2 and 3 are required for inhibition of visceral nociceptors by benzamil. | 2.08e-05 | 2 | 159 | 2 | 17467171 | |
| Pubmed | Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer. | 2.08e-05 | 2 | 159 | 2 | 38696842 | |
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 2.08e-05 | 2 | 159 | 2 | 16465597 | |
| Pubmed | XPB mediated retroviral cDNA degradation coincides with entry to the nucleus. | 2.08e-05 | 2 | 159 | 2 | 21167544 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 2.08e-05 | 2 | 159 | 2 | 16414020 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 28474168 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16835333 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24892992 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19337309 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 14659506 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 10842183 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8663148 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 17531389 | ||
| Pubmed | G quadruplexes are genomewide targets of transcriptional helicases XPB and XPD. | 2.08e-05 | 2 | 159 | 2 | 24609361 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23083890 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31169471 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 25793736 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11335038 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11278765 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 22234153 | ||
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 2.08e-05 | 2 | 159 | 2 | 16496311 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 38602289 | ||
| Pubmed | Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis. | 2.08e-05 | 2 | 159 | 2 | 26187040 | |
| Pubmed | ZNF609 RHOXF2 TAF6L DZANK1 MEGF6 NUTM2B MAPKBP1 DMPK PUM1 KIF17 WNK2 NLK | 2.53e-05 | 608 | 159 | 12 | 16713569 | |
| Pubmed | Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. | 6.21e-05 | 3 | 159 | 2 | 15987792 | |
| Pubmed | Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. | 6.21e-05 | 3 | 159 | 2 | 20513427 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 27760826 | ||
| Pubmed | PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells. | 6.21e-05 | 3 | 159 | 2 | 32294598 | |
| Pubmed | Up-regulation of acid-sensing ion channels in the capsule of the joint in frozen shoulder. | 6.21e-05 | 3 | 159 | 2 | 26033064 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 17466626 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 14990679 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 23846336 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 18562707 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 18801682 | ||
| Pubmed | The phosphatase PHLPP controls the cellular levels of protein kinase C. | 6.21e-05 | 3 | 159 | 2 | 18162466 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 14976185 | ||
| Pubmed | Generation of DNA single-strand displacement by compromised nucleotide excision repair. | 6.21e-05 | 3 | 159 | 2 | 22863773 | |
| Pubmed | Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance. | 6.21e-05 | 3 | 159 | 2 | 18948618 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 11597768 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 28618956 | ||
| Pubmed | Role of acid-sensing ion channels in hypoxia- and hypercapnia-induced ventilatory responses. | 6.21e-05 | 3 | 159 | 2 | 29474404 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 23109675 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 17177258 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 31186034 | ||
| Pubmed | Acid-sensing ion channels contribute to the effect of acidosis on the function of dendritic cells. | 6.21e-05 | 3 | 159 | 2 | 21321108 | |
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 6.21e-05 | 3 | 159 | 2 | 26542179 | |
| Pubmed | Acid sensing ion channels regulate neuronal excitability by inhibiting BK potassium channels. | 6.21e-05 | 3 | 159 | 2 | 22960074 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 19590043 | ||
| Pubmed | Identification and Function of Acid-sensing Ion Channels in RAW 264.7 Macrophage Cells. | 6.21e-05 | 3 | 159 | 2 | 30074209 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 22456610 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 34663797 | ||
| Pubmed | Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma. | 6.21e-05 | 3 | 159 | 2 | 26245343 | |
| Pubmed | Heteromultimers of DEG/ENaC subunits form H+-gated channels in mouse sensory neurons. | 6.21e-05 | 3 | 159 | 2 | 11854527 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 25620205 | ||
| Pubmed | Modulation of Acid-sensing Ion Channel 1a by Intracellular pH and Its Role in Ischemic Stroke. | 6.21e-05 | 3 | 159 | 2 | 27402850 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 23382212 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 17386267 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 22157923 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 12820975 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 18077458 | ||
| Pubmed | Subunit-dependent high-affinity zinc inhibition of acid-sensing ion channels. | 6.21e-05 | 3 | 159 | 2 | 15470133 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 20498078 | ||
| Pubmed | Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells. | 6.21e-05 | 3 | 159 | 2 | 17805295 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 24945731 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 27838878 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 19114557 | ||
| Pubmed | Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. | 6.21e-05 | 3 | 159 | 2 | 34348155 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP36 KDM3A LAMB4 POLR1A MYCBP2 TAF6L UBR5 OTUD6B KRT77 USP32 SHPRH PHLPP1 PYGL MPP7 PHLPP2 | 6.26e-05 | 1005 | 159 | 15 | 19615732 |
| Pubmed | Rrn3 becomes inactivated in the process of ribosomal DNA transcription. | 8.61e-05 | 19 | 159 | 3 | 12646563 | |
| Pubmed | POLR1A LRCH3 DHX30 CCDC47 MACF1 PYGL AKAP13 PUM1 UHRF2 DYNC1H1 HDLBP | 1.08e-04 | 601 | 159 | 11 | 33658012 | |
| Pubmed | 1.14e-04 | 103 | 159 | 5 | 10819331 | ||
| Pubmed | 1.24e-04 | 4 | 159 | 2 | 15471860 | ||
| Pubmed | 1.24e-04 | 4 | 159 | 2 | 20805893 | ||
| Pubmed | 1.24e-04 | 4 | 159 | 2 | 19934020 | ||
| Pubmed | PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth. | 1.24e-04 | 4 | 159 | 2 | 21986499 | |
| Pubmed | PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. | 1.24e-04 | 4 | 159 | 2 | 21804599 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 6.47e-05 | 120 | 159 | 5 | chr17q23 | |
| GeneFamily | Cadherin related | 4.44e-08 | 17 | 110 | 5 | 24 | |
| GeneFamily | Acid sensing ion channel subunits | 3.62e-04 | 5 | 110 | 2 | 290 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 7.55e-04 | 7 | 110 | 2 | 1268 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 1.00e-03 | 8 | 110 | 2 | 1125 | |
| GeneFamily | Adenosine deaminases acting on RNA | 1.00e-03 | 8 | 110 | 2 | 1303 | |
| GeneFamily | PHD finger proteins | 2.22e-03 | 90 | 110 | 4 | 88 | |
| GeneFamily | Fibronectin type III domain containing | 2.96e-03 | 160 | 110 | 5 | 555 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-07 | 183 | 159 | 8 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.96e-07 | 188 | 159 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.12e-07 | 189 | 159 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.64e-07 | 197 | 159 | 8 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.71e-07 | 135 | 159 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.33e-07 | 200 | 159 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-06 | 169 | 159 | 7 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-06 | 169 | 159 | 7 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-06 | 181 | 159 | 7 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-06 | 181 | 159 | 7 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-06 | 181 | 159 | 7 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 183 | 159 | 7 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-06 | 183 | 159 | 7 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.51e-06 | 184 | 159 | 7 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 4.67e-06 | 185 | 159 | 7 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 4.67e-06 | 185 | 159 | 7 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-06 | 186 | 159 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.19e-06 | 188 | 159 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.76e-06 | 191 | 159 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 5.96e-06 | 192 | 159 | 7 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.17e-06 | 193 | 159 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 15-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 6.38e-06 | 194 | 159 | 7 | 5c1218d239c88082496924653ed2a092dc44a906 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.38e-06 | 194 | 159 | 7 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.60e-06 | 195 | 159 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.60e-06 | 195 | 159 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.53e-06 | 199 | 159 | 7 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.78e-06 | 200 | 159 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.94e-06 | 137 | 159 | 6 | 2a5d2a99a2c532480d00b80a4885514a8a5c80fa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 147 | 159 | 6 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 160 | 159 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.40e-05 | 160 | 159 | 6 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 160 | 159 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-05 | 167 | 159 | 6 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.26e-05 | 169 | 159 | 6 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.26e-05 | 169 | 159 | 6 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.26e-05 | 169 | 159 | 6 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.48e-05 | 171 | 159 | 6 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.48e-05 | 171 | 159 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 172 | 159 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 172 | 159 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-05 | 173 | 159 | 6 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 178 | 159 | 6 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.36e-05 | 178 | 159 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.36e-05 | 178 | 159 | 6 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.50e-05 | 179 | 159 | 6 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-05 | 181 | 159 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-05 | 181 | 159 | 6 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 181 | 159 | 6 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.78e-05 | 181 | 159 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-05 | 182 | 159 | 6 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.93e-05 | 182 | 159 | 6 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-05 | 182 | 159 | 6 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 5.24e-05 | 184 | 159 | 6 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-05 | 184 | 159 | 6 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.40e-05 | 185 | 159 | 6 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.56e-05 | 186 | 159 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 5.73e-05 | 187 | 159 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.73e-05 | 187 | 159 | 6 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.88e-05 | 59 | 159 | 4 | ebc80c32b56e97c3ab3ac5ae00f06f7f2bcc3d39 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.88e-05 | 59 | 159 | 4 | 719728ed089762ae79cbfbe56c4171d70361a772 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.88e-05 | 59 | 159 | 4 | 55954d610f5a813ef15ab5e898c5ad309fc9e319 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.90e-05 | 188 | 159 | 6 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.90e-05 | 188 | 159 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.08e-05 | 189 | 159 | 6 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 189 | 159 | 6 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 189 | 159 | 6 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.08e-05 | 189 | 159 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 6.08e-05 | 189 | 159 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.08e-05 | 189 | 159 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 189 | 159 | 6 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.08e-05 | 189 | 159 | 6 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.26e-05 | 190 | 159 | 6 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|normal_Lung / Location, Cell class and cell subclass | 6.26e-05 | 190 | 159 | 6 | 2185db6007404a2b22325f91460dd17635be9bba | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-05 | 190 | 159 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.26e-05 | 190 | 159 | 6 | 103e78c2233c3ee0c215a9dafe70705477e9ee5e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.26e-05 | 190 | 159 | 6 | 9b0ad888eb20acc011904d8593bc32bdef18d050 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.26e-05 | 190 | 159 | 6 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.44e-05 | 191 | 159 | 6 | b680e0c35f1004be36f9f0680ae3c62952e2b607 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 6.63e-05 | 192 | 159 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.63e-05 | 192 | 159 | 6 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 192 | 159 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.63e-05 | 192 | 159 | 6 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-05 | 192 | 159 | 6 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 192 | 159 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 6.83e-05 | 193 | 159 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.83e-05 | 193 | 159 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.83e-05 | 193 | 159 | 6 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 193 | 159 | 6 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 193 | 159 | 6 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 7.02e-05 | 194 | 159 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.02e-05 | 194 | 159 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-05 | 194 | 159 | 6 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 7.22e-05 | 195 | 159 | 6 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.39e-05 | 121 | 159 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.43e-05 | 196 | 159 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-05 | 197 | 159 | 6 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-05 | 197 | 159 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 3.79e-05 | 307 | 155 | 9 | EFO_0004612, EFO_0020946 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.36e-04 | 148 | 155 | 6 | C0279702 | |
| Disease | obesity (implicated_via_orthology) | 1.48e-04 | 215 | 155 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Photosensitive Trichothiodystrophy | 1.63e-04 | 4 | 155 | 2 | C1866504 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.17e-04 | 103 | 155 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Endometrial Stromal Sarcoma | 2.71e-04 | 5 | 155 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 4.06e-04 | 6 | 155 | 2 | C0334488 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0800611 | |
| Disease | childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0004847, EFO_0008361, MONDO_0005405 | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 4.06e-04 | 6 | 155 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 4.06e-04 | 6 | 155 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | asphyxia neonatorum (biomarker_via_orthology) | 4.06e-04 | 6 | 155 | 2 | DOID:11088 (biomarker_via_orthology) | |
| Disease | Trichothiodystrophy Syndromes | 4.06e-04 | 6 | 155 | 2 | C1955934 | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 4.06e-04 | 6 | 155 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.57e-04 | 121 | 155 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.57e-04 | 121 | 155 | 5 | EFO_0004612, EFO_0005271 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 5.90e-04 | 128 | 155 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 5.90e-04 | 128 | 155 | 5 | C0007134 | |
| Disease | Global developmental delay | 7.02e-04 | 133 | 155 | 5 | C0557874 | |
| Disease | free cholesterol in large HDL measurement | 8.10e-04 | 79 | 155 | 4 | EFO_0022157 | |
| Disease | Xeroderma pigmentosum | 9.63e-04 | 9 | 155 | 2 | cv:C0043346 | |
| Disease | Abnormality of the face | 9.63e-04 | 9 | 155 | 2 | C4025871 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.31e-03 | 227 | 155 | 6 | EFO_0004346, EFO_0010736 | |
| Disease | Basal cell carcinoma | 1.46e-03 | 11 | 155 | 2 | C0007117 | |
| Disease | Tremor | 1.46e-03 | 11 | 155 | 2 | C0040822 | |
| Disease | Occupational Diseases | 1.46e-03 | 11 | 155 | 2 | C0028797 | |
| Disease | ceramide measurement | 1.56e-03 | 235 | 155 | 6 | EFO_0010222 | |
| Disease | S-warfarin measurement | 1.74e-03 | 97 | 155 | 4 | EFO_0803323 | |
| Disease | hearing impairment | 1.80e-03 | 98 | 155 | 4 | C1384666 | |
| Disease | triacylglycerol 54:4 measurement | 1.83e-03 | 46 | 155 | 3 | EFO_0010422 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.06e-03 | 13 | 155 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | cardioembolic stroke | 2.09e-03 | 170 | 155 | 5 | EFO_1001976 | |
| Disease | high density lipoprotein particle size measurement | 2.09e-03 | 170 | 155 | 5 | EFO_0008592 | |
| Disease | lipoprotein measurement | 2.32e-03 | 105 | 155 | 4 | EFO_0004732 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.33e-03 | 50 | 155 | 3 | EFO_0022247 | |
| Disease | thalamus volume change measurement | 2.39e-03 | 14 | 155 | 2 | EFO_0021496 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.39e-03 | 14 | 155 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Intellectual Disability | 2.59e-03 | 447 | 155 | 8 | C3714756 | |
| Disease | hair morphology measurement | 2.90e-03 | 54 | 155 | 3 | EFO_0007821 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.21e-03 | 56 | 155 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.21e-03 | 56 | 155 | 3 | EFO_0022251 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.22e-03 | 364 | 155 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | facial pigmentation measurement | 3.38e-03 | 57 | 155 | 3 | EFO_0006942 | |
| Disease | colon cancer (is_marker_for) | 3.73e-03 | 59 | 155 | 3 | DOID:219 (is_marker_for) | |
| Disease | cholesterol in medium HDL measurement | 3.73e-03 | 59 | 155 | 3 | EFO_0021903 | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.91e-03 | 60 | 155 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.91e-03 | 60 | 155 | 3 | EFO_0022233 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.91e-03 | 60 | 155 | 3 | EFO_0022237 | |
| Disease | free cholesterol in HDL measurement | 4.09e-03 | 61 | 155 | 3 | EFO_0022264 | |
| Disease | neuroimaging measurement | HDAC9 ADAMTS3 RBBP5 FAT3 METTL4 IRAG1 ARHGEF11 SULF2 KIAA1755 MACF1 ROBO3 ABHD12 WNK2 | 4.32e-03 | 1069 | 155 | 13 | EFO_0004346 |
| Disease | diet measurement, HOMA-B | 4.42e-03 | 19 | 155 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | response to methotrexate, neurotoxicity | 4.42e-03 | 19 | 155 | 2 | EFO_0011057, GO_0031427 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.49e-03 | 291 | 155 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 4.59e-03 | 127 | 155 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | PR interval | 4.78e-03 | 495 | 155 | 8 | EFO_0004462 | |
| Disease | lobe attachment | 4.84e-03 | 207 | 155 | 5 | EFO_0007667 | |
| Disease | total lipids in very large HDL measurement | 5.11e-03 | 66 | 155 | 3 | EFO_0022312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLAPLSVENILTHEQ | 196 | Q8NCV1 | |
| EVFITLLDVNDHPPQ | 561 | Q96JP9 | |
| LQEQLHSVPLSRDIP | 81 | Q63HQ2 | |
| PIEDGVNLSLEHLQP | 131 | P48507 | |
| EAQIDDEAHPVLLQP | 1176 | Q12802 | |
| DEAHPVLLQPVAKEL | 1181 | Q12802 | |
| ARLFPNLPELIEIHN | 776 | O15085 | |
| EHENIIVAIAPLLEN | 221 | Q8IY22 | |
| DPLLPSVAQAVQHLQ | 141 | Q8TAB5 | |
| LQNPDIVLVHYLNVP | 136 | O94983 | |
| LIPENRAHLSPEVQL | 731 | Q9ULD4 | |
| LLENVLPAHVAPQFI | 841 | Q8NFM4 | |
| PPSVQEEHGQLLALL | 1161 | Q7L2E3 | |
| HILQVTILDINDNPP | 1511 | Q9H251 | |
| QLVPPQTDVLLHIDV | 381 | Q9BV10 | |
| LLDVNLQIPDPHLAD | 116 | Q16515 | |
| LPPAQDQPLVEANHL | 271 | Q96D15 | |
| PCILHFQLLLENPVQ | 101 | Q9Y5E4 | |
| LDKPEQFLHELAQIP | 1121 | Q68DA7 | |
| LILHAEDDPVVPFQL | 326 | Q8N2K0 | |
| RLLHVVVVDANDNPP | 806 | Q14517 | |
| HPELVEGLVLINVDP | 151 | Q9UGV2 | |
| NHLVHLPEELAELPL | 206 | Q96II8 | |
| GLQLPQEIPFHELQL | 86 | Q02779 | |
| TVLATDPLLHQDPVQ | 106 | Q9UMX2 | |
| VPIHQLDIPVDNPIE | 241 | Q15842 | |
| IDLELHNPKAIAVDP | 321 | Q9NZR2 | |
| QIDQQPPRLLIVHIA | 16 | Q8TC57 | |
| LPQEQIQAELSPAHD | 16 | Q9BRQ3 | |
| INPVPVDLHEQQLSL | 231 | Q4G0N4 | |
| DQGLLLPAPAVEHIV | 71 | Q86Z02 | |
| DEVVVHLAPLNPLLL | 86 | Q5JYT7 | |
| LQEEPPLVIINVFDH | 826 | A9Z1Z3 | |
| PELELALFLVQEPHV | 141 | Q9NR23 | |
| NKDPITIVDVPAHLQ | 116 | Q96A33 | |
| QQPHENDVAALLKPI | 96 | P40123 | |
| PAGHIIDLVNDQLPD | 126 | Q9Y6F6 | |
| DNNLDHIPLPLPENL | 246 | Q99645 | |
| LEQLLIHQPEDPIPF | 31 | Q96MA6 | |
| VEVIVLDVNENLHPP | 1016 | Q9NYQ8 | |
| LALEALQAQVQAAPP | 131 | Q9H6K4 | |
| IPPNAAALEAAQDLI | 316 | Q96LB8 | |
| PLSLQEVDEQPQHPL | 11 | P30086 | |
| HICLDFIPELIAQPE | 1036 | Q9H0H0 | |
| ELLAALPAQLQPHVD | 16 | Q5T2T1 | |
| LPAQLQPHVDSQEDL | 21 | Q5T2T1 | |
| STHAPLPEVQLLLQQ | 591 | Q6AI08 | |
| PELIVHPVLDSPNAV | 121 | Q8IW45 | |
| TDAHLANPVLPDEVL | 301 | P18074 | |
| IPVQALLHLRHPEAE | 451 | P36915 | |
| DPQLPLNLAALQAHV | 386 | Q96FB5 | |
| IHSQEEPPIIDQLGL | 241 | Q9UHC3 | |
| APETEPIDVAAHLQL | 516 | Q9UGU5 | |
| NVLSALDILQPPHID | 196 | Q9UBE8 | |
| ILQHPDLQDVLLIPV | 86 | Q8TEA1 | |
| PSEGLQLHLPQVLAD | 311 | P78563 | |
| EHPLLEQVELPAVAS | 631 | Q8NDX5 | |
| EQLLEPHVQAPSLEP | 426 | Q09013 | |
| DQVVLNIVEVLPHLP | 756 | Q86WI3 | |
| ALIAQLPSPAIDHEQ | 5801 | Q9UPN3 | |
| NIELQGVPNDEVHPL | 456 | Q15291 | |
| ELHVILNNPILLPCE | 3996 | Q96RW7 | |
| NQEIHLSPITLQPAL | 266 | Q15256 | |
| QRILEHCLPDQTLPI | 1011 | Q14671 | |
| FGPPLDIQILHQVLD | 431 | O15118 | |
| LHIQVIVLDANDNPP | 226 | Q9Y5H0 | |
| LEQPNIVHDLPAAVL | 206 | O95456 | |
| KLLQEHLEEQEVAPP | 286 | O00459 | |
| PCVLHFQVVLENPLQ | 101 | Q9Y5E9 | |
| HILQTPIEIIQADSP | 236 | Q8N6M0 | |
| LNLNDFQVPDLHIPE | 2726 | P04114 | |
| LHDPVIVLIIPQEND | 801 | O15072 | |
| FALHAIDQINPPLNV | 231 | Q01344 | |
| AELEIANPPELQKHL | 426 | Q9Y4C1 | |
| ELPHPLLQQTEDQFL | 376 | Q14209 | |
| SLDIAVDNVPLEHPN | 616 | Q96BY6 | |
| REVLNAVPVLLHIPA | 221 | P10635 | |
| IISIHESPQPLLQDI | 31 | Q9H1R2 | |
| NIHLILEDVNDNPPV | 3116 | Q8TDW7 | |
| LLHQDVDLVCISIPP | 61 | Q3B7J2 | |
| DPALVDVLDQPLHTL | 116 | Q8IZJ0 | |
| ELDALGHELPVLAPQ | 36 | P55957 | |
| HPLSELLGIPLDQVN | 21 | Q6ZNC8 | |
| QEAVTLPPNLHLQIL | 866 | Q9Y2E5 | |
| ENLGLVAEPQAHAPI | 1266 | O60336 | |
| LALQSVHEPLQVPEE | 236 | P15848 | |
| LQQNIEIPEISLPIH | 196 | Q14204 | |
| VLDIHLPIPSQNLTD | 1506 | A4D0S4 | |
| PVLNDKHLDVPDIII | 26 | Q96GX8 | |
| ENLKQAVLPHQPVEA | 141 | P57679 | |
| HPDVIQHLLQDPVIR | 181 | P19447 | |
| IHELNLSQPIPLIIE | 2236 | A6NE01 | |
| ELEPLAEDILHQSPN | 976 | Q9UKV0 | |
| EAPLALQLQPQASLH | 271 | Q9NVP4 | |
| PLQLDLQPILAEALH | 641 | O75155 | |
| LDKLVEQLQVEDPHP | 3906 | Q9P225 | |
| RLEVIELPHSPQNLL | 661 | Q7Z5N4 | |
| IPHFSELPLDDQVIL | 286 | P19793 | |
| IEILEVNDHAPVLAP | 471 | P55291 | |
| SVILPCQVQHDPLLD | 516 | Q9P232 | |
| ADVNVLPIPDHKLIV | 396 | Q8N3J2 | |
| HLQVIILDNNPLQVP | 271 | Q5VUJ6 | |
| KLLPQPVIQHDVEAE | 391 | Q9P2E2 | |
| PPDEIHPLEILQAQI | 1146 | Q10571 | |
| LPHIAVLQDELPQLF | 471 | O75095 | |
| AVIHPQFLEELLSPD | 581 | Q8IVF1 | |
| AVIHPQFLEELLSPD | 581 | A6NNL0 | |
| AVIHPQFLEELLSPD | 581 | B1AL46 | |
| DVPPENIDQIHLSIA | 426 | Q86SS6 | |
| VLEPLAASINPLNDH | 246 | Q9Y6J9 | |
| LLINIIPEDHIPLNL | 691 | O95602 | |
| RPVIIQELENQHLCP | 1446 | Q9UPZ6 | |
| PPALQDIKELQHDVQ | 5426 | Q8WXH0 | |
| QPEQRPTAEEVHLLL | 381 | Q6ZMQ8 | |
| VDGLLVQLPLPEHID | 126 | P13995 | |
| APIEHVKQQLQDALP | 91 | Q7Z6Z6 | |
| VKQQLQDALPPDAHV | 96 | Q7Z6Z6 | |
| VDIDVEPPLHQALVL | 271 | Q9H469 | |
| ASLVILNEHNPPEID | 36 | Q8WVI7 | |
| LVEPILNPAHELQAI | 1601 | Q149N8 | |
| VDHPLSEQVHQPLLE | 111 | Q9P031 | |
| LLAVPVPGVNIEEHL | 841 | O75592 | |
| DGEIIPHIPANQEVL | 381 | P30520 | |
| PNVHAFTPLQLQELE | 136 | P0C7M4 | |
| LLSTEPHEEVPNILQ | 2046 | Q9UHV7 | |
| PHEEVPNILQQPLAL | 2051 | Q9UHV7 | |
| LIQHAQIPPEDSEII | 426 | P61764 | |
| ELEVAAINPNHPLAQ | 216 | Q8N122 | |
| LGVIPQDEQLHVLPL | 1696 | Q8NFU7 | |
| PHLPDQLVIVNETEA | 946 | Q2KHT3 | |
| NDIIQLLVRPDPDHL | 66 | Q96PU4 | |
| DVDIPLELVFHLPVN | 46 | Q9Y3V2 | |
| QALAEEDLQHLPPQP | 601 | Q5TCY1 | |
| DVLAALVNQPHLLVP | 261 | Q9NZQ8 | |
| AAFLLQHVQELPVPL | 196 | Q9HC29 | |
| QHVQELPVPLALPLE | 201 | Q9HC29 | |
| QNLPTLVEHIPLEVL | 561 | Q6ZVD8 | |
| IHENLTAIPPLIVAE | 1836 | Q13129 | |
| HLQNIDNVPLLVPLF | 961 | Q12767 | |
| LVHLLNLDQPPSLQD | 1251 | A6NE52 | |
| QAVPLAAQRVLHPDE | 1306 | Q96MS0 | |
| PADIVELHDINVEPL | 16 | O15391 | |
| PIHLLVPVVNNDISS | 261 | O15014 | |
| PNVHAFTPLQLQELE | 136 | Q9BQY4 | |
| VIFITNPLNEDLQHP | 3626 | Q86WI1 | |
| PDILEVHLPHAQPQD | 171 | Q02763 | |
| IPPVCVLHALLENVL | 441 | Q9BQI6 | |
| VLDVQHNQLLELPPN | 966 | O60346 | |
| PHLEVVPQELGLENS | 156 | P17022 | |
| ALDHAQPLLEHLQPQ | 71 | Q00G26 | |
| IHVPAPELQSDIIAI | 1006 | Q00341 | |
| QPLAETHEAPLAVQP | 1471 | Q9Y3S1 | |
| PDQVAIQLNDTHPAL | 331 | P06737 | |
| IQLNDTHPALAIPEL | 336 | P06737 | |
| LQEIVHQAADPETLP | 1746 | Q68DK2 | |
| NPHIVLNIDLAPTIL | 356 | Q8IWU5 | |
| PELVTPQDHEVALAN | 1456 | Q8NFA0 | |
| QVNEDLVSLPHQLPE | 786 | Q9P275 | |
| EAIPLADQPHLLQPN | 2046 | O95071 | |
| NLPEAQPPILVTAHE | 776 | B1ANS9 | |
| LPPQILADLENHALF | 406 | Q9NR64 | |
| IREAENIPVHLPNIQ | 1006 | P41229 | |
| IAIALPIHPIINNFV | 396 | Q9H3M0 | |
| INQSLLEPLHLEVDP | 141 | Q7Z794 | |
| EDDVHQRPLPQPALL | 321 | Q13094 |